-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2023.
- Arrowhead Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -1.38 USD/shares, a 43.8% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -4.67 USD/shares, a 175% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.92 USD/shares, a 15% decline from 2022.
- Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.67 USD/shares, a 22.8% decline from 2021.
- Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -1.36 USD/shares, a 61.9% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)